XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 24, 2022
Cash flows relating to operating activities    
Net income $ 291,418 $ 303,502
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 233,610 226,325
Stock-based compensation 52,527 51,548
Loss on debt extinguishment and amortization of other financing costs 2,975 3,054
Deferred income taxes (28,251) (26,323)
Loss on venture capital and strategic equity investments, net 9,246 20,068
Long-lived asset impairment charges 26,202 0
Loss on divestitures, net 995 0
Changes in fair value of contingent consideration arrangements 1,810 (15,420)
Other, net 13,192 31,574
Changes in assets and liabilities:    
Trade receivables and contract assets, net (59,081) (174,169)
Inventories (44,126) (76,283)
Accounts payable (26,531) 5,979
Accrued compensation 28,438 (32,734)
Deferred revenue (9,997) 53,565
Customer contract deposits (21,534) 16,234
Other assets and liabilities, net (7,938) (2,037)
Net cash provided by operating activities 462,955 384,883
Cash flows relating to investing activities    
Acquisition of businesses and assets, net of cash acquired (50,166) (283,392)
Capital expenditures (240,205) (235,709)
Purchases of investments and contributions to venture capital investments (36,322) (129,363)
Proceeds from sale of investments 3,953 3,104
Other, net (2,044) (6,945)
Net cash used in investing activities (324,784) (652,305)
Cash flows relating to financing activities    
Proceeds from long-term debt and revolving credit facility 333,034 2,798,665
Proceeds from exercises of stock options 19,658 17,710
Payments on long-term debt, revolving credit facility, and finance lease obligations (530,909) (2,524,387)
Purchase of treasury stock (24,016) (38,492)
Payments of contingent consideration (2,711) (10,356)
Purchases of additional equity interests, net 0 (30,533)
Other, net (4,145) (6,048)
Net cash (used in) provided by financing activities (209,089) 206,559
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (4,680) 10,726
Net change in cash, cash equivalents, and restricted cash (75,598) (50,137)
Cash, cash equivalents, and restricted cash, beginning of period 241,214 246,314
Cash, cash equivalents, and restricted cash, end of period $ 165,616 $ 196,177